Fast Five Quiz: How Prepared Are You to Address Chronic Myelogenous Leukemia?

Emmanuel C. Besa, MD

Disclosures

November 11, 2014

Chronic myelogenous leukemia (CML), also known as chronic myeloid leukemia, is a myeloproliferative disorder that accounts for 20% of all leukemias affecting adults. Approximately 85% of patients are diagnosed in the chronic phase and then progress to the accelerated and blast phases after 3-5 years. Currently, patients with CML have a 5-year survival rate of 50%-60%. Do you know the causes, findings, associated tests, and best treatment options for CML? Test your knowledge with this quick quiz.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....